Hippocratic AI reaches $1.64B valuation with new funding round
The startup Hippocratic AI develops AI tools for non-diagnostic patient care tasks, focusing on direct patient support.
Hippocratic AI has raised $141 million in a Series B funding round, bringing its valuation to $1.64 billion. Kleiner Perkins led the investment, building on previous funding rounds from General Catalyst, Andreessen Horowitz, and Nvidia. The company, founded less than two years ago, specialises in AI tools for non-diagnostic patient care tasks.
The startup focuses on addressing the shortage of healthcare workers by developing AI agents capable of handling pre-operating procedures, remote monitoring, and appointment preparation.
Most generative AI companies prioritise reducing administrative work, while Hippocratic AI centres its efforts on direct patient support.
In 2024, Hippocratic AI has already secured contracts with 23 health systems and insurers. The newly raised capital will support expansion into additional markets, including international growth.
About author
DW Team
The GIP Digital Watch Observatory team, consisting of over 30 digital policy experts from around the world, excels in the fields of research and analysis on digital policy issues. The team is backed by the creative prowess of Creative Lab Diplo and the technical expertise of the Diplo tech team.